Pluma, Jayson .
HRN: 21-60-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/04/2024
10/11/2024
IV
2.25g
Q12
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes